NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $76,827 | -56.5% | 61,957 | -75.4% | 0.00% | – |
| Q1 2023 | $176,731 | -69.0% | 251,431 | -0.2% | 0.00% | -100.0% |
| Q4 2022 | $569,432 | -14.1% | 251,961 | +21.6% | 0.00% | 0.0% |
| Q3 2022 | $662,860 | +18.8% | 207,144 | +41.0% | 0.00% | 0.0% |
| Q2 2022 | $558,000 | +80.0% | 146,891 | +155.3% | 0.00% | 0.0% |
| Q1 2022 | $310,000 | -55.5% | 57,541 | +11.5% | 0.00% | 0.0% |
| Q4 2021 | $697,000 | +35.6% | 51,626 | +80.4% | 0.00% | 0.0% |
| Q3 2021 | $514,000 | +5.8% | 28,614 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $486,000 | -68.3% | 28,293 | -63.1% | 0.00% | -66.7% |
| Q1 2021 | $1,535,000 | +252.1% | 76,744 | +198.9% | 0.00% | +200.0% |
| Q4 2020 | $436,000 | -3.8% | 25,672 | -5.9% | 0.00% | 0.0% |
| Q3 2020 | $453,000 | -30.5% | 27,279 | -3.1% | 0.00% | -50.0% |
| Q2 2020 | $652,000 | +5.7% | 28,156 | -18.6% | 0.00% | 0.0% |
| Q1 2020 | $617,000 | -17.1% | 34,582 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $744,000 | -49.7% | 34,449 | -57.6% | 0.00% | -33.3% |
| Q3 2019 | $1,480,000 | -49.1% | 81,249 | -0.6% | 0.00% | -50.0% |
| Q2 2019 | $2,907,000 | -3.1% | 81,713 | -8.5% | 0.01% | -14.3% |
| Q1 2019 | $3,001,000 | +0.2% | 89,302 | -2.0% | 0.01% | 0.0% |
| Q4 2018 | $2,995,000 | -45.9% | 91,126 | +0.4% | 0.01% | -36.4% |
| Q3 2018 | $5,536,000 | +22.6% | 90,805 | -1.8% | 0.01% | +10.0% |
| Q2 2018 | $4,514,000 | -94.1% | 92,436 | -87.1% | 0.01% | -93.8% |
| Q1 2018 | $76,037,000 | +53.5% | 715,571 | -13.7% | 0.16% | +57.3% |
| Q4 2017 | $49,543,000 | +2895.3% | 829,575 | +1103.9% | 0.10% | +2475.0% |
| Q3 2017 | $1,654,000 | +22.8% | 68,910 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $1,347,000 | 0.0% | 68,910 | +20.1% | 0.00% | 0.0% |
| Q1 2017 | $1,347,000 | +91.3% | 57,372 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $704,000 | -28.6% | 57,372 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $986,000 | -25.4% | 57,372 | -38.2% | 0.00% | -33.3% |
| Q2 2016 | $1,322,000 | +3.5% | 92,897 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,277,000 | +28.7% | 92,897 | +57.9% | 0.00% | +50.0% |
| Q4 2015 | $992,000 | -91.6% | 58,848 | -94.5% | 0.00% | -93.3% |
| Q3 2015 | $11,832,000 | -41.1% | 1,079,550 | -32.8% | 0.03% | -34.8% |
| Q2 2015 | $20,091,000 | +43.9% | 1,605,937 | +26.6% | 0.05% | +48.4% |
| Q1 2015 | $13,959,000 | -11.0% | 1,268,997 | +25.5% | 0.03% | -11.4% |
| Q4 2014 | $15,677,000 | +9.9% | 1,011,357 | -14.4% | 0.04% | +9.4% |
| Q3 2014 | $14,262,000 | +16.6% | 1,181,657 | +23.8% | 0.03% | +14.3% |
| Q2 2014 | $12,235,000 | -2.9% | 954,357 | -8.2% | 0.03% | -3.4% |
| Q1 2014 | $12,606,000 | -1.7% | 1,040,157 | -7.9% | 0.03% | -3.3% |
| Q4 2013 | $12,822,000 | +40.1% | 1,129,757 | +29.0% | 0.03% | +30.4% |
| Q3 2013 | $9,152,000 | +7.9% | 875,757 | +19.3% | 0.02% | 0.0% |
| Q2 2013 | $8,479,000 | – | 734,057 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |